Evaluation

1. Please rate this CME activity *

	Very Poor	Poor	Neutral	Good	Excellent
Overall Evaluation	Overall Evaluation - Very Poor	Overall Evaluation - Poor	Overall Evaluation - Neutral	Overall Evaluation - Good	Overall Evaluation - Excellent
Content	Content - Very Poor	Content - Poor	Content - Neutral	Content - Good	Content - Excellent
Usefulness	Usefulness - Very Poor	Usefulness - Poor	Usefulness - Neutral	Usefulness - Good	Usefulness - Excellent
Quality	Quality - Very Poor	Quality - Poor	Quality - Neutral	Quality - Good	Quality - Excellent

2. Please rate the extent to which each of the following learning objectives were met. *

(1=Strongly Disagree, 5= Strongly Agree)

	1	2	3	4	5
Discuss treatment guidelines and recommendations for appropriate patient assessment, treatment selection, and risk stratification strategies within dyslipidemia.	Discuss treatment guidelines and recommendations for appropriate patient assessment, treatment selection, and risk stratification strategies within dyslipidemia. - 1	Discuss treatment guidelines and recommendations for appropriate patient assessment, treatment selection, and risk stratification strategies within dyslipidemia. - 2	Discuss treatment guidelines and recommendations for appropriate patient assessment, treatment selection, and risk stratification strategies within dyslipidemia. - 3	Discuss treatment guidelines and recommendations for appropriate patient assessment, treatment selection, and risk stratification strategies within dyslipidemia. - 4	Discuss treatment guidelines and recommendations for appropriate patient assessment, treatment selection, and risk stratification strategies within dyslipidemia. - 5
Analyze available and emerging dyslipidemia therapeutics, including statin therapy and PCSK9 inhibitors.	Analyze available and emerging dyslipidemia therapeutics, including statin therapy and PCSK9 inhibitors. - 1	Analyze available and emerging dyslipidemia therapeutics, including statin therapy and PCSK9 inhibitors. - 2	Analyze available and emerging dyslipidemia therapeutics, including statin therapy and PCSK9 inhibitors. - 3	Analyze available and emerging dyslipidemia therapeutics, including statin therapy and PCSK9 inhibitors. - 4	Analyze available and emerging dyslipidemia therapeutics, including statin therapy and PCSK9 inhibitors. - 5
Formulate personalized treatment plans to accurately assess patient-specific characteristics, optimizing therapeutic selection to improve outcomes in dyslipidemia.	Formulate personalized treatment plans to accurately assess patient-specific characteristics, optimizing therapeutic selection to improve outcomes in dyslipidemia. - 1	Formulate personalized treatment plans to accurately assess patient-specific characteristics, optimizing therapeutic selection to improve outcomes in dyslipidemia. - 2	Formulate personalized treatment plans to accurately assess patient-specific characteristics, optimizing therapeutic selection to improve outcomes in dyslipidemia. - 3	Formulate personalized treatment plans to accurately assess patient-specific characteristics, optimizing therapeutic selection to improve outcomes in dyslipidemia. - 4	Formulate personalized treatment plans to accurately assess patient-specific characteristics, optimizing therapeutic selection to improve outcomes in dyslipidemia. - 5

3. How many patients do you see with dyslipidemia each month? *

4. After participating in this activity, how confident are you in your ability to: *

(1=NOT at all confident, 2=Somewhat confident, 3=Confident, 4=Very confident, 5=EXTREMELY confident, N/A=Not within the scope of my practice)

	1	2	3	4	5	N/A
Develop individualized treatment plans for patients with dyslipidemia?	Develop individualized treatment plans for patients with dyslipidemia? - 1	Develop individualized treatment plans for patients with dyslipidemia? - 2	Develop individualized treatment plans for patients with dyslipidemia? - 3	Develop individualized treatment plans for patients with dyslipidemia? - 4	Develop individualized treatment plans for patients with dyslipidemia? - 5	Develop individualized treatment plans for patients with dyslipidemia? - N/A
Apply current ACC/AHA guidelines to your everyday practice?	Apply current ACC/AHA guidelines to your everyday practice? - 1	Apply current ACC/AHA guidelines to your everyday practice? - 2	Apply current ACC/AHA guidelines to your everyday practice? - 3	Apply current ACC/AHA guidelines to your everyday practice? - 4	Apply current ACC/AHA guidelines to your everyday practice? - 5	Apply current ACC/AHA guidelines to your everyday practice? - N/A

5. As a result of participating in this activity, I will consider current clinical trial data on therapeutic targets to improve outcomes of patients with dyslipidemia. *

Yes

No

6. Do you feel the activity was fair balanced and free of commercial bias? *

Yes

No

If no, please explain.

7. What topics would you like to see in future CME activities?

8. Do you wish to be notified by email when new educational programs are offered by Elsevier?

Yes

No

9. Having completed this activity, how often do you NOW PLAN to use each of the following clinical practice strategies for your patients with dyslipidemia? *

(1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable to me)

	1	2	3	4	5	N/A
Utilize current recommendations and guidelines when managing patients with dyslipidemia	Utilize current recommendations and guidelines when managing patients with dyslipidemia - 1	Utilize current recommendations and guidelines when managing patients with dyslipidemia - 2	Utilize current recommendations and guidelines when managing patients with dyslipidemia - 3	Utilize current recommendations and guidelines when managing patients with dyslipidemia - 4	Utilize current recommendations and guidelines when managing patients with dyslipidemia - 5	Utilize current recommendations and guidelines when managing patients with dyslipidemia - N/A
Consider the application of PCSK9 therapeutics for patients with statin intolerance	Consider the application of PCSK9 therapeutics for patients with statin intolerance - 1	Consider the application of PCSK9 therapeutics for patients with statin intolerance - 2	Consider the application of PCSK9 therapeutics for patients with statin intolerance - 3	Consider the application of PCSK9 therapeutics for patients with statin intolerance - 4	Consider the application of PCSK9 therapeutics for patients with statin intolerance - 5	Consider the application of PCSK9 therapeutics for patients with statin intolerance - N/A
Apply knowledge from clinical trial data to develop individualized treatment plans to maximize patients at LDL-C goals	Apply knowledge from clinical trial data to develop individualized treatment plans to maximize patients at LDL-C goals - 1	Apply knowledge from clinical trial data to develop individualized treatment plans to maximize patients at LDL-C goals - 2	Apply knowledge from clinical trial data to develop individualized treatment plans to maximize patients at LDL-C goals - 3	Apply knowledge from clinical trial data to develop individualized treatment plans to maximize patients at LDL-C goals - 4	Apply knowledge from clinical trial data to develop individualized treatment plans to maximize patients at LDL-C goals - 5	Apply knowledge from clinical trial data to develop individualized treatment plans to maximize patients at LDL-C goals - N/A

Elsevier CME

2015 ACC Medical Meeting Reporter: Best Practices in Lipid Management for Patients with Dyslipidemia

Pre-Activity Questions

Course Video

Post-Activity Test

Evaluation

Credit

Certificate

Course navigation

You are here

2015 ACC Medical Meeting Reporter: Best Practices in Lipid Management for Patients with Dyslipidemia

Evaluation

Pre-Activity Questions

Course Video

Post-Activity Test

Evaluation

Credit

Certificate

Course navigation